The STAT3 inhibitor stattic overcome bortezomib-resistance in multiple myeloma via decreasing PSMB6.
Yuan C, Yuan M, Li W, Cheng H, Luo J, Zhang Q, Shi M, Niu M, Yang J, Sun Z, Yan Z, Xu K, Li Z, Yao Y.
Yuan C, et al. Among authors: zhang q.
Exp Cell Res. 2023 Aug 1;429(1):113634. doi: 10.1016/j.yexcr.2023.113634. Epub 2023 May 18.
Exp Cell Res. 2023.
PMID: 37207970